Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Prelude Therapeutics initiates phase I study of PRT-1419

Sep. 17, 2020

Sec61 protein secretion-interfering compounds presented by Kezar Life Sciences

Sep. 16, 2020

C4 Therapeutics patents new CRBN-targeting compounds

Sep. 16, 2020

Bioardis divulges new FGFR4 inhibitors

Sep. 16, 2020

SAB-402, a novel potent dual EGFR/HER4 tyrosine kinase inhibitor with promising activity in vivo

Sep. 16, 2020

Dosing starts in phase I study of exoIL-12

Sep. 16, 2020

Novel IRE1 inhibitors identified by Genentech

Sep. 15, 2020

Cerepeut describes new quinazolinone compounds

Sep. 15, 2020

Newave Pharmaceutical divulges BTK inhibitors

Sep. 15, 2020

Oxygen grows tumors but shrinks metastasis chances

Sep. 15, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...